PEPAXTO (melphalan flufenamide) is only approved for use by the Food and Drug Administration (FDA) in the United States. It is not approved by any other regulatory agency, including the European Medicines Agency (EMA) or registered for use in any European country.
Note that registration conditions, prescribing information, and information about the patient support program only apply in the United States.
This site is intended for healthcare professionals only.
You are now entering the Clinical Development area of the exhibit. This information reflects information on investigational compounds and/or investigational uses of approved products. The safety and efficacy of these investigational agents have not been established.
Please rotate your device to use Oncopeptides Virtual Booth
ONCOPEPTIDES SUPPORT LAZAREX CANCER FOUNDATION
Oncopeptides wants to make a donation to Lazarex Cancer Foundation. Enter your name and hit the "PROMPT DONATION" button below to send a $10 donation from Oncopeptides.
Our donation goal is $20,000.
YOU CAN INVITE OTHERS TO JOIN
Select one of the logos below to share this site and invite others to join the cause.